about
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Adv...
Read More
3.40
-0.02
(-0.58%)
441.1K
XNAS Volume
XNAS 03 Jul, 2025 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Moderately Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Neuronetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..